Inhibiting signaling in B cell malignancies


20Dec2017 14:00 - 15:00

PhD defence ceremony

B cells are lymphocytes that express and produce antibodies. The malignant counterparts of B cells, B cell leukemias and lymphomas, imitate the homing and migration behaviour of their non-malignant cells of origin. Signaling plays a crucial role in the growth, homing and retention of malignant B cells Martin van Rooij describes the molecular details of these signaling pathways, together with promising drugable targets of these pathways, which can be used to treat B cell malignancies.

M.F.M. de Rooij: Targeting the BCR Signalosome in B Cell Malignancies.


Prof. S.T. Pals


Dr M. Spaargaren


  • Agnietenkapel

    Oudezijds Voorburgwal 229 - 231 | 1012 EZ Amsterdam
    +31 (0)20 525 2362

    Go to detailpage


This event is open to the public.

Published by  University of Amsterdam